1. Pink Sheet
  2. >>Biosimilars & Generics
  3. >>Generics

Vanda Falls Again As Teva, US FDA Win Judgment In Tasimelteon Approval Case

 
• By Dean Rudge

In its latest legal case, Vanda lost its case against the FDA and Teva over the alleged unlawful approval of the Israeli firm’s generic Hetlioz.

Hand push red Red Cross mark to choose cancellation item , Approve and reject business and document
The court ruled against Vanda in its three challenges of the FDA approval decision. (Shutterstock)

A US district court ruled that the US Food and Drug Administration’s approval of Teva’s generic version of Vanda Pharmaceuticals Hetlioz (tasimelteon) was not unlawful, marking another defeat for the serial litigator.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Legal & IP